Sarker, Jyotirmoy https://orcid.org/0000-0002-2528-5458
Tice, Jeffrey A.
Rind, David M.
Walton, Surrey M.
Funding for this research was provided by:
Institute for Clinical and Economic Review
Article History
Accepted: 14 November 2024
First Online: 2 December 2024
Declarations
:
: This study was supported by funding from the Institute for Clinical and Economic Review (ICER), Boston, MA. Members from the funding organization (ICER) are co-authors on the manuscript and have contributed to the concept and design of the study, data acquisition, analysis and interpretation and drafting and revision of the manuscript. Publication of study results was not contingent upon the sponsor’s approval or censorship of the manuscript.
: Mr. Sarker and Dr. Walton received financial support from the Institute for Clinical and Economic Review (ICER) via a contract between ICER and the University of Illinois Chicago, during the conduct of the study. Mr. Sarker received funding from AbbVie, and from Merck, outside the submitted work. Dr. Walton received funding from Roche outside the submitted work. Dr. Tice received financial support from ICER during the conduct of the study. Dr Rind is an employee of ICER and further report grants from Arnold Ventures, grants from Blue Cross Blue Shield of MA, grants from California Healthcare Foundation, grants from The Commonwealth Fund, and grants from The Peterson Center on Healthcare during the conduct of the study; other funding/support was received from Aetna, America’s Health Insurance Plans, Anthem, AbbVie, Alnylam, AstraZeneca, Biogen, Blue Shield of CA, Cambia Health Services, CVS, Editas, Express Scripts, Genentech/Roche, GlaxoSmithKline, Harvard Pilgrim, Health Care Service Corporation, other from Health Partners, Johnson & Johnson (Janssen), Kaiser Permanente, LEO Pharma, Mallinckrodt, Merck, Novartis, National Pharmaceutical Council, Premera, Prime Therapeutics, Regeneron, Sanofi, Spark Therapeutics, United Healthcare, HealthFirst, Pfizer, Boehringer-Ingelheim, uniQure, Evolve Pharmacy Solutions, Humana, and Sun Life outside the submitted work.
: All relevant data and materials supporting the findings of this study are included in the submitted files. Additional data or materials, if required, can be obtained upon reasonable request by contacting the corresponding author.
: Not applicable.
: Not applicable.
: Not applicable.
: The model is considered proprietary. Requests for access may be directed to Dr. Surrey Walton (walton@uic.edu), who will determine on a case-by-case basis whether the request can be granted.
: Concept and design: Sarker, Rind, Walton. Acquisition of data: Sarker, Tice. Analysis and interpretation of data: Sarker, Tice, Walton. Drafting of the manuscript: Sarker, Walton. Critical revision of the paper for important intellectual content: Tice, Rind, Walton. Statistical analysis: Sarker, Walton. Administrative, technical, or logistic support: Walton, Rind. Supervision: Rind, Walton. All authors have read and approved the final version of the manuscript.